BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38531846)

  • 21. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schisandrin B suppresses osteosarcoma lung metastasis
    Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The circular RNA circ-ITCH acts as a tumour suppressor in osteosarcoma via regulating miR-22.
    Ren C; Liu J; Zheng B; Yan P; Sun Y; Yue B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3359-3367. PubMed ID: 31387405
    [No Abstract]   [Full Text] [Related]  

  • 25. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ; Dong BK; Fan M; Jiang WX
    Int J Clin Exp Pathol; 2015; 8(10):12410-8. PubMed ID: 26722427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
    Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
    Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.
    Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Wang Y; Deng Y
    J Physiol Biochem; 2020 May; 76(2):279-290. PubMed ID: 32100243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
    Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
    Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caulis Spatholobi extracts inhibit osteosarcoma growth and metastasis through suppression of CXCR4/PI3K/AKT signaling.
    Jiang Y; Gao Y; Li X; He F; Liu Y; Wang R
    J Orthop Surg Res; 2023 Dec; 18(1):985. PubMed ID: 38129870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2.
    Zhang D; Liu H; Wang W; Xu G; Yin C; Wang S
    Cancer Biol Ther; 2022 Dec; 23(1):1-16. PubMed ID: 36316642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
    Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
    Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy.
    Qi S; Xu L; Han Y; Chen H; Cheng A
    Cell Cycle; 2022 Sep; 21(18):1980-1995. PubMed ID: 35575588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B; Xu L; Dai EN; Tian JX; Li JM
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30442873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
    Ma K; Zhang C; Li W
    Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morusin Inhibits Human Osteosarcoma via the PI3K-AKT Signaling Pathway.
    Zhang Y; Weng Q; Chen J; Han J
    Curr Pharm Biotechnol; 2020; 21(13):1402-1409. PubMed ID: 32297574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.
    Da W; Tao L; Zhu Y
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013357
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Yang B; Wang B; Wang G; Cao W; Wang Q; Pu H; An W
    Anticancer Agents Med Chem; 2023; 23(13):1577-1586. PubMed ID: 37139674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.